Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments close on Thursday 25 April at 4:30pm because of system upgrades. We expect to open them again on Friday 26 April at 8am the latest.

SMINT: Stage 2 application FP7-HEALTH-13-INNOVATION-1. Novel targets for cardiovascular disease treatment.

Reference number
Coordinator RED GLEAD DISCOVERY AB
Funding from Vinnova SEK 118 983
Project duration December 2012 - February 2013
Status Completed

Last updated 25 November 2019

Reference number 2012-04514

Page statistics